Stock listing
Praxis Precision Medicines, Inc.
Selected listing: PRAX · NASDAQ · USD · US
Praxis Precision Medicines, Inc. (NASDAQ:PRAX), Health Technology. Latest release Oct 2, 2026: Praxis Precision Medicines, Inc. Announces Inducement Grants…
- Ticker
- NASDAQ:PRAX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. is a public company traded under the ticker PRAX in the American market. Praxis focuses on developing innovative treatments for neurological diseases, aiming to address significant unmet medical needs.
Latest news from Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 1, 2026
Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
July 30, 2026
Praxis Precision Medicines and Remagine Labs Announce Strategic Collaboration to Develop Transdermal Ulixacaltamide for Essential Tremor
July 6, 2026
Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies
June 29, 2026
Events
Research Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. company profile
View the public company page for Praxis Precision Medicines, Inc. on 6ix.
Praxis Precision Medicines, Inc. news
Read company news and market updates connected to Praxis Precision Medicines, Inc..
Praxis Precision Medicines, Inc. investor events
Find investor webinars, events, and replay context for Praxis Precision Medicines, Inc..